USE OF GINSENG EXTRACT, GINSENOSIDE AND GINSENOSIDE DERIVATIVE IN THE PREPARATION OF MEDICINE OR HEALTH CARE PRODUCT FOR TREATING CYTOMEGALOVIRUS INFECTION DISORDERS

Title:

USE OF GINSENG EXTRACT, GINSENOSIDE AND GINSENOSIDE DERIVATIVE IN THE PREPARATION OF MEDICINE OR HEALTH CARE PRODUCT FOR TREATING CYTOMEGALOVIRUS INFECTION DISORDERS

Document Type and Number:

WIPO Patent Application WO/2016/184290

Kind Code:

A1

Abstract:

Disclosed is the use of a ginseng extract, a ginsenoside and a ginsenoside derivative in the preparation of a medicine or health care product for the treatment of human cytomegalovirus infection-related diseases. The related diseases comprise a patient suffering from cardiovascular and cerebrovascular diseases, organ transfers, being perinatal, tumors, burns, AIDS and other diseases being infected by the human cytomegalovirus during treatment. Experiments demonstrate that the ginseng extract, the ginsenoside and the ginsenoside derivative are significant and quickly effective in the treatment of diseases of human cytomegalovirus infections, are less toxic and have less side effects, so that same are a safe, efficient, stable medicine or health care product with a simple preparation process for treating human cytomegalovirus virus infections, and are suitable for industrial production and easily propagated. They provide a new source of medicine for treating human cytomegalovirus infections.

More Like This:

WO/2022/089418	FUSION PROTEIN OF RECOMBINANT TRUNCATED FLT3 LIGAND AND HUMAN ANTIBODY FC
JPH0267218	VIRUS GENOME INACTIVATOR
JP7014811	Inhibitor of Bruton's tyrosine kinase

Inventors:

FU LI (CN)
WANG KAIQIAN (CN)
HUI MIN (CN)
LI FAN (CN)
FAN HONGYU (CN)
WANG SHUO (CN)

Application Number:

PCT/CN2016/079844

Publication Date:

November 24, 2016

Filing Date:

April 21, 2016

Export Citation:

Click for automatic bibliography generation Help

Assignee:

FU LI (CN)

International Classes:

A61P31/12; A61K36/9068

Domestic Patent References:

WO2000050054A1

2000-08-31

Foreign References:

CN103536884A

2014-01-29

Other References:

AN, NING ET AL.: "Effect of 20(R) ginsenoside Rg3 on protein expression of lung cancer cell line", CHINESE JOURNAL OF LUNG CANCER, vol. 11, no. 3, 30 June 2008 (2008-06-30), pages 311 - 320, XP055331675, ISSN: 1009-3419
See also references of EP 3295950A4

Attorney, Agent or Firm:

BEIJING YUANBEN INTELLECTUAL PROPERTY LAW OFFICE (CN)
北京元本知识产权代理事务所 (CN)

Download PDF:

View/Download PDF PDF Help

Previous Patent: HARQ SENDING AND RECEIVING METHOD AND DEVICE, AND NODE

Next Patent: FRAME HEADER DETECTION METHOD AND DEVICE